HealthEquity, Inc. (NASDAQ:HQY) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of HealthEquity, Inc. (NASDAQ:HQY) have earned an average rating of “Moderate Buy” from the seventeen research firms that are covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation, twelve have issued a buy recommendation and two have given a strong buy recommendation to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $120.2667.

Several analysts recently weighed in on HQY shares. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $120.00 price objective on shares of HealthEquity in a research note on Friday, December 5th. Wall Street Zen downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. BTIG Research reaffirmed a “buy” rating and set a $130.00 price target on shares of HealthEquity in a report on Thursday, December 4th. Jefferies Financial Group upped their price objective on shares of HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a research report on Wednesday, September 3rd. Finally, JMP Securities set a $122.00 price objective on shares of HealthEquity in a research note on Thursday, December 4th.

Insider Activity at HealthEquity

In related news, EVP Delano Ladd sold 1,500 shares of the business’s stock in a transaction on Thursday, November 20th. The stock was sold at an average price of $104.56, for a total transaction of $156,840.00. Following the sale, the executive vice president owned 75,479 shares in the company, valued at $7,892,084.24. The trade was a 1.95% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Elimelech Rosner sold 10,959 shares of the company’s stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $95.45, for a total value of $1,046,036.55. Following the completion of the transaction, the executive vice president directly owned 45,742 shares of the company’s stock, valued at approximately $4,366,073.90. The trade was a 19.33% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 15,740 shares of company stock valued at $1,498,084 in the last 90 days. 1.50% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On HealthEquity

Institutional investors have recently added to or reduced their stakes in the business. Farther Finance Advisors LLC raised its stake in shares of HealthEquity by 232.4% during the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock valued at $26,000 after acquiring an additional 172 shares during the last quarter. WPG Advisers LLC acquired a new stake in HealthEquity in the first quarter valued at $28,000. True Wealth Design LLC increased its holdings in HealthEquity by 3,522.2% in the third quarter. True Wealth Design LLC now owns 326 shares of the company’s stock valued at $31,000 after purchasing an additional 317 shares during the period. Caitong International Asset Management Co. Ltd bought a new position in HealthEquity during the 2nd quarter worth $33,000. Finally, Cullen Frost Bankers Inc. lifted its holdings in HealthEquity by 172.3% during the 2nd quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock worth $37,000 after buying an additional 224 shares during the period. 99.55% of the stock is owned by institutional investors.

HealthEquity Stock Performance

Shares of NASDAQ:HQY opened at $95.50 on Friday. HealthEquity has a 1 year low of $74.07 and a 1 year high of $116.65. The stock has a market capitalization of $8.16 billion, a price-to-earnings ratio of 43.81, a price-to-earnings-growth ratio of 1.38 and a beta of 0.18. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13. The company’s 50 day simple moving average is $97.22 and its 200 day simple moving average is $96.44.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The firm had revenue of $322.16 million for the quarter, compared to the consensus estimate of $320.92 million. During the same quarter last year, the business posted $0.78 EPS. The company’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, research analysts predict that HealthEquity will post 2.32 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.